This announcement is a separate document:
沃森生物：关于终止与苏州艾博生物科技有限公司合作开发的新型冠状病毒mRNA疫苗临床试验的公告
Walvax Biotechnology: Announcement on termination of clinical trial of new coronavirus mRNA vaccine in cooperation with Suzhou Abogen Biosciences Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.